AstraZeneca will buy longtime partner FibroGen's China unit for about $160 million to gain rights to its anemia drug in the ...

U.S. President Donald Trump will meet on Thursday with chief executives from major drugmakers, a White House official ...

Celebrity doctor Mehmet Oz, MD, Trump's pick to head CMS, pledged to divest millions from drug, medical, and insurance ...

At the State of Black Health second annual summit hosted by BlackDoctor.org in partnership with USA TODAY, corporate leaders ...

Local companies are developing technologies that they hope could replace a painful poke with something that feels more like ...

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

As the industry advances, pharmaceutical companies must address a critical challenge: how to meet this growing demand while managing the escalating costs and complexities associated with ...

The theory behind leucovorin's use for autism postulates that some children have a blockage in the transport of folic acid into the brain that potentially contributes to neurological symptoms.

Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.

Popular weight-loss therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss.

Dr. Mehmet Oz holds millions of dollars worth of shares in health insurance, fertility, pharmaceutical and vitamin companies ...

CVS is fighting to protect its PBM business as Trump and Congress look for ways to take out the pharmacy "middlemen." ...